Related Experiment Videos
[Acute complications in sickle cell disease].
Anoosha Habibi1, Dora Bachir, Bertrand Godeau
1Service de médecine interne, unité des maladies génétiques du globule rouge et d'aphérèse, CHU Henri Mondor, 94010 Créteil. anoosha.habibi@hmn.ap-hop-paris.fr
La Revue Du Praticien
|November 24, 2004
Summary
Sickle cell disease, an inherited blood disorder, causes severe pain crises and organ damage. Transfusion is the primary treatment for severe acute vaso-occlusive crises in patients with this condition.
Area of Science:
- Hematology
- Inherited disorders
- Vascular complications
Context:
- Sickle cell disease (SCD) is a genetic disorder affecting hemoglobin.
- Acute vaso-occlusive crisis (VOC) is a primary complication of SCD.
- VOC leads to significant morbidity, hospitalizations, and mortality.
Purpose:
- To summarize the clinical significance of acute vaso-occlusive crisis in sickle cell disease.
- To highlight the main treatment strategies for severe acute VOC.
Summary:
- Sickle cell disease is characterized by abnormal hemoglobin, leading to red blood cell sickling.
- Acute vaso-occlusive crisis is the most common and severe complication, causing severe pain and acute chest syndrome.
- This crisis can result in multi-organ failure, with blood transfusion being the primary therapeutic intervention.
Impact:
- Understanding VOC is crucial for managing sickle cell disease patients.
- Effective management of VOC can reduce hospitalizations and improve patient outcomes.
- Highlights the importance of transfusion therapy in severe SCD complications.